Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, June 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 3 news outlets
policy: 1 policy source

patent: 1 patent

Readers on

mendeley: 110 Mendeley

Summary News Policy documents Patents

So far, Altmetric has seen 1 patent that references this research output.

METHODS OF DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS

Application WO-2020219960-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.